BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2162789)

  • 21. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
    Auchus RJ; Sarafoglou K; Fechner PY; Vogiatzi MG; Imel EA; Davis SM; Giri N; Sturgeon J; Roberts E; Chan JL; Farber RH
    J Clin Endocrinol Metab; 2022 Feb; 107(3):801-812. PubMed ID: 34653252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The corticotrophin releasing factor test: a valuable and rapid procedure for the differential diagnosis of hirsutism.
    Georgala S; Schulpis K; Tolis G
    J Int Med Res; 1992 Feb; 20(1):40-4. PubMed ID: 1314743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease.
    Lobo RA; Goebelsmann U
    Am J Obstet Gynecol; 1980 Nov; 138(6):720-6. PubMed ID: 6254362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of angiotensin II to stimulate increases in concentrations of adrenal androgens, 17-hydroxyprogesterone, or adrenocorticotropin in congenital 21-hydroxylase deficiency.
    Wisgerhof M; Mellinger RC; Zafar MS
    J Clin Endocrinol Metab; 1983 Mar; 56(3):627-31. PubMed ID: 6296191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women.
    Chetkowski RJ; DeFazio J; Shamonki I; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):595-8. PubMed ID: 6321532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficit of 21 beta-hydroxylase. Clinico-functional parameters.
    Gangemi M; Benato M; Guacci AM; Meneghetti G
    Clin Exp Obstet Gynecol; 1983; 10(4):176-81. PubMed ID: 6323056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associations.
    Chrousos GP; Loriaux DL; Mann D; Cutler GB
    Horm Res; 1982; 16(4):193-200. PubMed ID: 6290362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian steroidogenesis in an adrenalectomized girl with 21-hydroxylase deficiency.
    Zachmann M; Manella B; Kempken B; Knorr-Muerset G; Atares M; Prader A
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):575-82. PubMed ID: 6094047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Defects of adrenal steroidogenesis in patients with hirsutism].
    Salinas Vert I; Audí Parera L; Granada Ybern ML; Lucas Martín A; Pizarro Lozano E; Foz Sala M; Sanmartí Sala A
    Med Clin (Barc); 1998 Feb; 110(5):171-6. PubMed ID: 9547720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
    Speiser PW; New MI
    J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the one hour adrenocorticotrophic hormone test in the diagnosis of attenuated 21-hydroxylase deficiency.
    Innanen VT; Vale JM
    J Clin Pathol; 1990 Jun; 43(6):493-5. PubMed ID: 2166094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Acquired" adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorders as congenital adrenal hyperplasia.
    New MI; Lorenzen F; Pang S; Gunczler P; Dupont B; Levine LS
    J Clin Endocrinol Metab; 1979 Feb; 48(2):356-9. PubMed ID: 218988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset adrenal hyperplasia in north Indian hirsute women.
    Mithal A; Ammini AC; Godbole MM; Khurana ML; Raj D; Karmarkar MG; Ahuja MM
    Horm Res; 1988; 30(1):1-4. PubMed ID: 2851524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
    Müller OA; Stalla GK; von Werder K
    Horm Res; 1987; 25(4):185-98. PubMed ID: 3034758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
    Granoff AB; Chasalow FI; Blethen SL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in patients with adrenocortical insufficiency due to hypothalamic and pituitary disorders.
    Tsukada T; Nakai Y; Koh T; Tsujii S; Inada M; Nishikawa M; Shinoda H; Kawai I; Takezawa N; Imura H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):758-60. PubMed ID: 6321536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche.
    Lucky AW; Rosenfield RL; McGuire J; Rudy S; Helke J
    J Clin Endocrinol Metab; 1986 May; 62(5):840-8. PubMed ID: 3007557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of adrenocorticotropin secretion in a patient with 17 alpha-hydroxylase deficiency.
    Moreira AC; Leal AM; Castro M
    J Clin Endocrinol Metab; 1990 Jul; 71(1):86-91. PubMed ID: 2164530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.